Ciproquinol

Quick links to important sections

Ciproquinol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ciproquinol

Quick Facts

Property Description
Active ingredient Ciprofloxacin
Form Tablet, Solution for infusion, Topical solutions
Pharmacological class Fluoroquinolone Antibiotic (Second-Generation)
General purpose Elimination of susceptible bacteria
Origin Synthetic (chemically derived)

Ciproquinol: Definition and Pharmacological Classification

Ciproquinol is a synthesized prescription-only antimicrobial agent whose active ingredient is Ciprofloxacin, designated for the management of bacterial infections. It belongs to the broad class of drugs known as fluoroquinolones, specifically recognized as a second-generation quinolone. This classification identifies Ciproquinol not as a naturally derived substance, but as a product of chemical synthesis.

This designation reflects the evolution of the drug's core chemistry, which provides a broad-spectrum efficacy against a wider range of bacterial pathogens, including certain Gram-negative and Gram-positive strains. The development of this second-generation structure, characterized by a cyclopropyl group, is supported by pharmacological studies demonstrating enhanced activity against critical bacteria. The drug is defined as a bactericidal agent, meaning its primary action is designed to actively and directly kill susceptible bacteria.

Composition, Origin, and Available Forms

The medication contains the single-ingredient product, Ciprofloxacin (often present as Ciprofloxacin hydrochloride), formulated into multiple pharmaceutical preparations to allow for flexible use. The principal forms include the common Tablet for oral intake, Ophthalmic solution and Otic solution for targeted topical administration, and a Solution for infusion for systemic, parenteral (intravenous) delivery.

This variety of forms is essential because it allows the drug to be administered locally where the infection is confined, or rapidly throughout the body via the intravenous route when a severe systemic infection requires immediate and widespread action. The capability for both oral and intravenous delivery, often facilitating a smooth transition from hospital-based treatment to outpatient therapy, is a key differentiating feature of this agent.

General Purpose and Broad-Spectrum Utility

The general purpose of Ciproquinol is the elimination of susceptible bacteria within the body, which aids in the swift resolution of bacterial diseases. Its utility stems from its unique physiological action that targets the essential genetic machinery of bacteria, effectively halting their reproduction.

This function means Ciproquinol provides an effective way to address infections caused by various bacterial types, differentiating it from agents that may only target a small set of pathogens. By focusing on destroying the root cause of the infection at a cellular level, Ciproquinol helps to neutralize the threat, thereby working to restore the body’s health and functional status.

What side effects are possible with Ciproquinol?

Possible Side Effects and Safety Information

The safety profile of Ciproquinol (Ciprofloxacin) is classified by regulatory authorities based on the frequency and the physiological systems affected, in line with official SmPC and FDA labeling. The adverse reactions are grouped into categories such as Gastrointestinal disorders, Nervous system disorders, and Musculoskeletal and connective tissue disorders.


Frequency Classification of Adverse Reactions

Adverse reactions are formally categorized by incidence rates defined in regulatory documents:

  • Common (ge 1/100 to < 1/10): Typically include nausea and diarrhoea, along with abnormal liver function tests (e.g., increased transaminases).
  • Uncommon (ge 1/1,000 to < 1/100): May involve headache, dizziness, vomiting, and generalized abdominal pain.
  • Rare (ge 1/10,000 to < 1/1,000): Covers more infrequent events such as seizures, tinnitus, tachycardia, and photosensitivity.
  • Very Rare (< 1/10,000): Includes severe events like liver necrosis (potentially progressing to hepatic failure) and life-threatening anaphylactic shock.

Serious Adverse Reactions and Safety Constraints

The official labeling highlights specific serious and potentially irreversible adverse reactions. These include a regulatory warning regarding the risks of tendinitis and tendon rupture, peripheral neuropathy (nerve damage), and certain Central Nervous System (CNS) effects. These potentially disabling reactions can occur within hours to weeks after treatment initiation.

Regulatory documents also detail safety constraints, such as a documented risk of Aortic Aneurysm and Dissection and severe blood sugar disturbances, including hypoglycaemic coma. Furthermore, use is advised against in patients with a history of Myasthenia Gravis due to the potential for exacerbation of muscle weakness, and a mandatory contraindication exists for concomitant use with Tizanidine.

Overdose and Emergency Response

Overdose Scope: Official Regulatory Information

If an excessive dose of Ciproquinol (Ciprofloxacin) is taken, the official regulatory profile documents that urgent medical help must be sought immediately. The primary acute manifestations of overdose reported in regulatory documents include reversible renal toxicity (specifically crystalluria and hematuria) and potential effects on the central nervous system (CNS).

Overdose Presentation
Reversible renal toxicity (crystalluria, hematuria)
CNS effects (seizures, confusion, dizziness, tremor)
Gastrointestinal effects (nausea, vomiting)

Management and Emergency Actions

The medical management of Ciproquinol overdose is focused on supportive care and reducing absorption of the drug. Specific actions cited in official documents include:

  • Gastric evacuation: Procedures such as induction of vomiting or gastric lavage may be performed shortly after acute ingestion.
  • Supportive treatment: Careful observation of the patient and administration of symptomatic treatment are required.
  • Hydration: Adequate hydration must be maintained to help prevent crystalluria.

There is no specific pharmacological antidote identified for Ciproquinol overdose. Regulatory data indicates that less than 10% of the drug is removed via hemodialysis or peritoneal dialysis. Patients with pre-existing renal impairment are noted as being at a higher risk for drug accumulation, which increases the potential for overdose toxicity.

Therapeutic Uses of Ciproquinol

What Ciproquinol Treats: Main Uses and Benefits

Ciproquinol is used across several domains of care to manage groups of symptoms and conditions caused by specific types of bacterial infection. Its role is to provide targeted therapeutic support to help patients regain comfort and stability. The therapeutic uses for Ciprofloxacin (the active ingredient in Ciproquinol) cover various acute bacterial infections.

Used in situations involving certain distressing symptoms, Ciproquinol is applied across therapeutic domains such as the urinary tract, lower respiratory tract, skin and soft tissue, and the gastrointestinal system. It helps address symptom clusters that may become intense or disruptive, such as those related to physical discomfort or systemic imbalance. The treatment contributes to easing the overall symptom load during periods of acute bacterial infection.

Quick Fact: Support for Functional Stability

It is relevant in contexts marked by increased discomfort or tension and assists with maintaining functional stability when symptoms create noticeable physiological strain.


Relief from Urinary Tract and Bladder Discomfort

This medication is commonly used across conditions presenting with acute episodes of bacterial infection in the urinary tract. It helps address symptom clusters that may become intense or disruptive, and assists with maintaining functional stability when symptoms that interfere with daily functioning become noticeable.

Eligibility and Restrictions for Use

Ciproquinol (Ciprofloxacin) eligibility is defined by regulatory agencies based on patient age, pre-existing conditions, and physiological status. Absolute contraindications prohibit use in two primary groups:

  • Patients with a history of hypersensitivity (allergic reaction) to ciprofloxacin or any other drug in the fluoroquinolone class.
  • Patients who are concurrently taking the muscle relaxant Tizanidine.

Conditional and Restricted Use

Comorbidity Exclusions: The medicine must be avoided in patients with a known history of Myasthenia Gravis due to the potential for muscle weakness to worsen. Caution is also advised in patients with epilepsy or other central nervous system disorders.

Age Restrictions: Routine use is not recommended in pediatric patients (le 18 years) due to the risk of joint damage (arthropathy). Use is restricted only to specific, severe infections, such as complicated urinary tract infections, pyelonephritis, or inhalational anthrax, where the benefit outweighs this risk. Older adults do not require a standard dose adjustment based on age alone, but dose adjustments are mandatory for those with renal impairment.

Physiological Status: Use is not recommended during pregnancy and lactation because the drug is known to pass into breast milk and has limited safety data in humans.

What should I know about interactions with other medicines?

Ciproquinol Interactions with other medicines and products

Ciproquinol may interact with several medicinal products, supplements, and foods, primarily through effects on drug absorption and metabolism, as documented in regulatory information.

Contraindicated Combinations and Significant Interactions

Co-administration of Ciproquinol and Tizanidine is contraindicated due to Ciproquinol’s strong inhibition of the CYP1A2 enzyme. This interaction significantly increases Tizanidine plasma concentrations, raising the risk of severe side effects, including hypotension and sedation.

Ciproquinol can also inhibit the metabolism of other CYP1A2 substrates, such as Theophylline and Clozapine, necessitating close monitoring and potential adjustment of the co-administered drug’s dose to prevent toxicity.

Interactions Affecting Absorption

Absorption of Ciproquinol is significantly reduced by products containing multivalent cations (e.g., iron, zinc, aluminum, magnesium, or calcium). This includes antacids, sucralfate, and certain mineral supplements. To minimize chelation and maintain adequate drug levels, Ciproquinol must be taken at least 2 hours before or 6 hours after these products.

Ciproquinol absorption is also reduced when taken with dairy products (milk, yogurt) and calcium-fortified juices due to calcium binding.

Pharmacodynamic and Other Interactions

The co-administration of Ciproquinol with corticosteroids increases the risk of tendon injury. Caution is also required when Ciproquinol is combined with other QT-prolonging agents (e.g., Class IA/III anti-arrhythmics) due to the risk of additive effects.

Mechanism of Action

Targeting the Bacterial Genetic Engine

Ciprofloxacin acts by targeting two core bacterial enzymes: DNA Gyrase and Topoisomerase IV. These enzymes are essential for managing the physical structure of the bacterial genome, specifically enabling DNA replication and separation. The drug stabilizes the complex between the enzyme and cleaved DNA, thereby physically blocking the cell's ability to copy and separate its genetic material.


Causing Irreversible DNA Poisoning

This molecular interaction is a form of DNA poisoning, where the enzyme complex is converted into a lethal roadblock on the DNA strand. This action prevents the broken DNA from being relinked, leading to a catastrophic accumulation of DNA double-strand breaks (DSBs). This overwhelming damage exceeds the bacterial cell's repair capacity, triggering rapid, irreversible bacterial cell death (bacteriolysis).


Mechanistic Limitations and Resistance

The function of this mechanism depends on the drug reaching a sufficient concentration at the target site. This concentration can be lowered by bacterial resistance mechanisms, such as efflux pumps that actively expel the drug from the cell, or by genetic mutations in the Gyrase and Topoisomerase IV enzymes that reduce Ciprofloxacin’s binding affinity, thereby reducing the drug's capacity to execute the killing mechanism.

Dosage and Administration Information

Official Administration and Dosing of Ciproquinol

Ciproquinol (Ciprofloxacin) is used according to strict guidelines established by regulatory authorities. The method of administration is approved for oral intake, via tablets or suspension, and for intravenous (IV) infusion for systemic delivery. Oral immediate-release forms are typically taken twice daily (q12h), while extended-release tablets are taken once daily (q24h).


Dosage and Frequency Rules

Standard adult doses for immediate-release oral therapy generally range from 250 mg to 750 mg per dose. Intravenous dosing is commonly 200 mg to 400 mg per administration. The duration of therapy is highly dependent on the condition being addressed, ranging from short courses of 3 days for acute uncomplicated conditions to extended regimens of up to 60 days for certain prophylactic uses.


Administration Conditions

Ciproquinol tablets may be taken with or without food, though some regulatory labels specify that extended-release forms should be taken with a main meal. A critical rule for oral use is the mandated separation from multivalent cation-containing products, such as mineral supplements or antacids, which must be taken several hours before or after the dose. The IV solution must be administered via a slow infusion over a 60-minute period.


Population-Specific Adjustments

Dose adjustment is officially required for patients with renal impairment, where the dosing interval or amount must be modified based on the patient's creatinine clearance. For pediatric patients, dosing is calculated based on body weight (e.g., 10 mg/kg to 20 mg/kg), up to the maximum adult dose.

Recent Clinical Evidence

Ciproquinol: Research Evidence Overview

Research into Ciproquinol has primarily focused on Randomized Controlled Trials (RCTs) to meet the regulatory standards required for authorization across its major uses. These studies were designed to evaluate the medicine's role in managing acute bacterial infections of the urinary tract, lower respiratory tract, skin and soft tissue, and the gastrointestinal system.

In these trials, researchers monitored two core outcomes: bacteriological eradication (the clearance of the targeted pathogen) and clinical status change (the resolution of acute symptoms and indicators of functional stability). The evidence for these core indications was assessed as compliant with the standards required by regulatory bodies, with reported outcomes concentrated on the acute treatment phase and short-term follow-up.


Research Gaps and Areas of Uncertainty

The research base, while compliant with regulatory standards, presents certain limitations. The primary studies mostly focused on short timeframes; consequently, follow-up durations were limited, and long-term effects are not fully established. Uncertainty remains regarding the durability of the initial response and recurrence rates.

Furthermore, evidence is limited in specific patient groups, such as children and individuals with certain complex pre-existing conditions. Research describes how various patient cohorts were included, but data for certain subgroups are often insufficient in high-level summaries. Comparative evidence is lacking in some areas, and certainty remains low where findings were mixed or variable across studies, highlighting areas for continued research.

Key Studies & References Ciprofloxacin: MedlinePlus Drug Information (National Library of Medicine)

Frequently Asked Questions (FAQ)

Common questions about Ciproquinol (FAQ)

Q: Is Ciproquinol considered safe for older adults?

Official information indicates that a standard dose adjustment is not required based on age alone. However, a change in dosage is mandatory if a patient has impaired kidney function (renal impairment), which can be common in older adults. Safety warnings note that serious side effects, such as nerve damage or tendon issues, require caution in this population.

Q: What kind of research has been done on the long-term safety of Ciproquinol?

Regulatory safety reviews note that some serious adverse reactions linked to this class of antibiotics, such as tendon damage (tendinopathy) and nerve damage (peripheral neuropathy), can be disabling and potentially irreversible in rare cases. These effects can be persistent, lasting for extended periods after treatment is discontinued. These findings inform the serious warnings present in the official labeling.

Q: What does the research say about Ciproquinol use during pregnancy?

Ciproquinol is not recommended for use during pregnancy. This caution is based on animal studies which showed that the drug can cause joint damage in immature animals. Official documents state that there are limited or no adequate data on human use to establish its safety profile during pregnancy.

Q: Can Ciproquinol impact blood sugar levels?

Yes. Official regulatory warnings state that Ciproquinol can be associated with severe blood sugar disturbances. This can include both high blood sugar (hyperglycemia) and dangerously low blood sugar (hypoglycemia), with the risk of hypoglycemic coma in rare circumstances.

Q: Can Ciproquinol interact with common over-the-counter pain relievers?

Official product information advises that Ciproquinol must be used with caution when combined with non-steroidal anti-inflammatory drugs (NSAIDs), such as certain common pain relievers. The combination requires caution, as regulatory information reports an increased risk of Central Nervous System (CNS) effects, including seizures.

Q: Why is hydration often mentioned when taking Ciproquinol?

This practice is noted to help manage the risk of crystal formation in the urine, a condition known as crystalluria, based on regulatory guidance. Official medication guides recommend that patients drink plenty of fluids while taking Ciproquinol.

Q: Can Ciproquinol be crushed or split?

Official administration instructions indicate that the tablets must be swallowed whole. Regulatory information specifies that both immediate-release and extended-release tablets should not be split, crushed, or chewed because this can alter how the medicine works and is absorbed by the body.

Q: What information is available about Ciproquinol use in people with kidney problems?

Official regulatory documents clearly state that dosage adjustment is required for patients with impaired kidney function (renal impairment). The dose and/or frequency of the medicine must be modified based on the patient's creatinine clearance to ensure the drug is cleared from the body effectively.

Q: What information is available about Ciproquinol use in people with liver problems?

Regulatory labeling notes that Ciproquinol use has been associated with liver damage (hepatotoxicity), including the very rare occurrence of potentially fatal liver necrosis. Official documents do not provide a specific dose adjustment for people with pre-existing liver impairment, though caution is generally advised.

Q: Is Ciproquinol known to cause long-term health issues?

Regulatory bodies have issued warnings because some serious side effects, such as tendon damage and peripheral neuropathy (nerve damage), can be disabling and potentially irreversible (long-lasting) in rare cases. These long-lasting effects are a key focus of regulatory safety constraints.

Q: Can Ciproquinol affect sleep patterns?

Yes, official consumer information and product documents list disturbances of the nervous system as documented side effects. Insomnia (difficulty sleeping) and nightmares have been reported as common or uncommon adverse reactions.

Q: What happens if a dose of Ciproquinol is missed?

Official medication guides advise that if a regular dose is missed, it should be taken as soon as it is remembered. However, this must be done only if the next dose is not due too soon, as directed in the official prescribing information. It is explicitly stated that one must not double the dose to make up for the missed one.

Q: Is Ciproquinol effective against viruses or fungi?

Official product information states Ciproquinol is a fluoroquinolone antibacterial agent used to eliminate susceptible bacteria. It is not indicated or approved for use in treating illnesses caused by viruses or fungi.

Q: Are there any specific lifestyle changes recommended while on Ciproquinol?

Regulatory information advises patients to take specific precautions. These include avoiding excessive sunlight or artificial UV light due to a risk of skin reactions (photosensitivity). Additionally, due to the regulatory warning regarding tendon injury, the avoidance of strenuous physical activity is a consideration.

Q: What is the general success rate reported in clinical trials for Ciproquinol?

Studies assessed outcomes using measures like clinical cure rates and microbiological eradication rates. These rates have been reported to be as high as 85–93% in certain trials for approved infections, demonstrating compliance with regulatory standards for efficacy data.

Q: How does the body eliminate Ciproquinol?

Ciproquinol is primarily eliminated from the body through the kidneys (renal excretion). In individuals with normal kidney function, the drug is typically cleared from the system within about 20 to 24 hours after the last dose, based on its approximate half-life.

Q: Are there any studies comparing Ciproquinol's use in different age groups?

Regulatory documents acknowledge that the use of Ciproquinol is assessed differently across age groups. Its use in pediatric patients is restricted to specific, severe infections only, due to the recognized risk of joint damage, which demonstrates a risk/benefit profile distinct from that in adults.

Q: Is Ciproquinol used for preventing infections?

Yes. Ciproquinol is approved for prophylactic use, meaning it can be used to prevent certain infections, such as after exposure to specific pathogens like inhalational anthrax.

Q: Can Ciproquinol affect birth control effectiveness?

Yes. Official drug interaction information states that antibiotics like Ciproquinol may reduce the effects of oral contraceptives containing ethinyl estradiol in some women. Regulatory documents note that an alternative or additional form of birth control may be necessary during and immediately after treatment.

Q: What is the typical length of time Ciproquinol is used for?

The duration of therapy is highly dependent on the condition being treated, based on regulatory guidelines. Treatment ranges widely from short courses of 3 days for acute, uncomplicated conditions to extended regimens that can last up to 60 days for certain prophylactic uses.

Q: What are the most commonly reported side effects of Ciproquinol?

Regulatory documents classify the most frequent adverse reactions as Common (affecting at least 1 in 100 people). These commonly reported side effects typically include nausea and diarrhoea.

Q: Are there specific symptoms that signal an emergency side effect from Ciproquinol?

Official patient resources describe specific symptoms that warrant immediate medical attention, as they may signal a severe reaction. These include critical symptoms like trouble breathing or closing of the throat, swelling of the lips, tongue, or face, and severe gastrointestinal issues like bloody/watery diarrhea.

Q: Can Ciproquinol cause mental health or mood changes?

Yes. Regulatory warnings from drug safety updates state that Ciproquinol can cause a range of psychiatric adverse reactions. These include symptoms like anxiety, confusion, depression, hallucinations, and severe reactions like psychotic episodes, with rare reports of progression to suicidal thoughts or attempts.

How should Ciproquinol be stored and disposed of?

How to Store and Dispose of Ciproquinol

Storage and disposal requirements for Ciproquinol (Ciprofloxacin) are strictly defined by regulatory guidelines to ensure stability and safety.


Official Storage Conditions

Requirement Rule based on Regulatory Labeling
Temperature Tablets should be kept at controlled room temperature (e.g., below 30 C). The oral suspension can be stored at room temperature or refrigerated [NIH PubChem; FDA].
Protection Store away from excessive heat, moisture, and direct light in a tightly closed, original container [FDA].
Stability Limit The reconstituted oral suspension must be discarded after 14 days [FDA].
Prohibited The product must not be frozen [FDA].
Security Mandatory to keep out of the sight and reach of children [FDA].

Disposal Requirements

Unused or expired Ciproquinol should be managed through an official drug take-back program. If this is unavailable, the medication must be mixed with an unappealing substance, placed in a sealed container, and disposed of in household trash to prevent misuse and environmental contamination. It must not be allowed to enter the sewage system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ciproquinol found in:

A-Z Index: